Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Assets (2019 - 2025)

Historic Assets for AVITA Medical (RCEL) over the last 7 years, with Q3 2025 value amounting to $63.7 million.

  • AVITA Medical's Assets fell 2137.3% to $63.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.7 million, marking a year-over-year decrease of 2137.3%. This contributed to the annual value of $111.6 million for FY2023, which is 1361.23% up from last year.
  • According to the latest figures from Q3 2025, AVITA Medical's Assets is $63.7 million, which was down 2137.3% from $58.1 million recorded in Q2 2025.
  • AVITA Medical's 5-year Assets high stood at $128.1 million for Q1 2021, and its period low was $58.1 million during Q2 2025.
  • Moreover, its 5-year median value for Assets was $97.8 million (2022), whereas its average is $96.0 million.
  • As far as peak fluctuations go, AVITA Medical's Assets soared by 6739.77% in 2021, and later crashed by 3380.78% in 2025.
  • Over the past 5 years, AVITA Medical's Assets (Quarter) stood at $116.0 million in 2021, then fell by 15.3% to $98.3 million in 2022, then grew by 13.61% to $111.6 million in 2023, then fell by 27.4% to $81.1 million in 2024, then fell by 21.37% to $63.7 million in 2025.
  • Its last three reported values are $63.7 million in Q3 2025, $58.1 million for Q2 2025, and $69.6 million during Q1 2025.